Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising adoption of CDMOs for outsourcing manufacturing activities
3.2.1.2 Increasing demand for generic drugs
3.2.1.3 Growing number of strategic partnerships between pharmaceutical companies and CDMOs
3.2.2 Industry pitfalls & challenges
3.2.2.1 Quality control challenges
3.2.2.2 Intellectual property concerns
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter’s analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Tablets
5.3 Capsules
5.4 Powders
5.5 Granules
5.6 Other products
Chapter 6 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Immediate release
6.3 Delayed release
6.4 Controlled release
Chapter 7 Market Estimates and Forecast, By Therapeutic Area, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Oncology
7.3 Cardiovascular diseases
7.4 Metabolic disorders
7.5 Neurological disorders
7.6 Infectious diseases
7.7 Gastrointestinal diseases
7.8 Other therapeutic areas
Chapter 8 Market Estimates and Forecast, By Service, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Drug product development
8.3 Fill finish product manufacturing
8.4 API manufacturing
8.5 Packaging and labelling
8.6 Other applications
Chapter 9 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Large size companies
9.3 Medium & small size companies
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Netherlands
10.3.7 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
10.6.4 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 Aenova Group
11.2 AbbVie Contract Manufacturing (AbbVie Inc.)
11.3 Boehringer Ingelheim International GmbH
11.4 Catalent, Inc.
11.5 Corden Pharma International
11.6 Jubilant Pharmova Limited
11.7 Lonza
11.8 NextPharma Technologies
11.9 Patheon Pharma Services (Thermo Fisher Scientific Inc.)
11.10 Siegfried Holding AG
